Interested In Learning More? Contact us to learn how XIFIN can help your business. Call us at (858) 436-2995 or click here to complete a brief information request form.
Without exception, XIFIN’s clients have increased their cash collections, and reduced bad debt and days sales outstanding.
AMS Reference Lab
— Janet Kaufman, Business Manager of AMS Reference Lab
Clarient
— Ron Andrews, CEO of Clarient
Myriad Genetics
— Todd Ogaard, Vice President of Myriad Genetics
NICL Laboratories
— Joel Welder, Comptroller of NICL Laboratories
North Shore LIJ
— Richard Tesoriero, Finance Director of North Shore LIJ
Physicians Reference Laboratory
— Dan Spragle, EVP and COO of Physicians Reference Laboratory
Piedmont Medical Laboratory
— Joe Skrisson, CEO of Piedmont Medical Laboratory
US Labs
— Judd Jessup, CEO of US Labs
Westcliff/LabWest
— Richard Nicholson, Former CEO of Westcliff/LabWest
AI BioTech, LLC
"Implementing RCM solutions that will help us navigate the reimbursement and regulatory complexities of the molecular diagnostics market is critical to drive rapid company growth,” said Bill Miller, CEO of AI BioTech, LLC. “XIFIN was the clear choice because the company has a solid reputation for achieving results, powerful web service technology, and a leadership team recognized for change advocacy and reform in the molecular DX and diagnostic services market. I am confident that our partnership with XIFIN will provide the framework we need to strategically manage our operations and drive growth and profitability.”"
— Bill Miller, CEO of AI BioTech, LLC

Sonora Quest Laboratories
"Given the complexity of healthcare billing, especially in the lab industry, SaaS will help us leverage external expertise without replicating resources in house. By utilizing the rules-based engines inherent in the XIFIN software, we will see efficiencies in our process, improvements in our reimbursement and revenue cycle, plus enhancements in our reporting capabilities. With these improvements, we expect to see an immediate return on our SaaS expenditures."
— David Lutich, CFO of Sonora Quest Laboratories









